MAM-2201 (Analytically Confirmed) Intoxication After "Synthacaine" Consumption

被引:20
作者
Lonati, Davide [1 ,2 ]
Buscaglia, Eleonora [1 ,2 ]
Papa, Pietro [4 ]
Valli, Antonella [4 ]
Coccini, Teresa [3 ]
Giampreti, Andrea [1 ,2 ]
Petrolini, Valeria Margherita [1 ,2 ]
Vecchio, Sarah [1 ,2 ]
Serpelloni, Giovanni [5 ]
Locatelli, Carlo Alessandro [1 ,2 ]
机构
[1] IRCCS Maugeri Fdn, Poison Control Ctr, Pavia, Italy
[2] IRCCS Maugeri Fdn, Natl Toxicol Informat Ctr, Toxicol Unit, Pavia, Italy
[3] IRCCS Maugeri Fdn, Inst Pavia, Lab Clin Toxicol, Pavia, Italy
[4] IRCCS Policlinico San Matteo Fdn, Clin Chem Serv, Lab Analyt Toxicol, Pavia, Italy
[5] Presidency Council Ministers, Dept Antidrug Policies, Rome, Italy
关键词
SYNTHETIC CANNABINOIDS; BENZOCAINE;
D O I
10.1016/j.annemergmed.2014.01.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Excitatory behavior, xerostomia, chest pain, severe dyspnea, tachycardia (150 beats/min), and mild hypertension (160/80 mm Hg) without ECG abnormalities were observed in a 20-year-old subject 6 hours after nasal insufflation (snorting) of a "legally" obtained white powdered substance sold as Synthacaine. A serum sample was found to contain MAM-2201 (11 ng/mL), a synthetic cannabinoid receptor agonist, and benzocaine. The patient's symptoms improved after administration of diazepam and intravenous fluids. Synthacaine was sold as legal cocaine, suggesting the user can expect an effect like that of cocaine. The pharmacologic receptor profile and chemical structure of MAM-2201 is similar to the synthetic cannabinoid receptor agonists AM-2201 and JWH-122 (2 potent synthetic cannabinoid receptor agonists with high affinity to cannabinoid receptors).
引用
收藏
页码:629 / 632
页数:4
相关论文
共 15 条
[1]   White powder, blue patient: Methaemoglobinaemia associated with benzocaine-adulterated cocaine [J].
Chakladar, Abhijoy ;
Willers, Johann W. ;
Pereskokova, Elena ;
Beaumont, Peter O. ;
Uncles, David R. .
RESUSCITATION, 2010, 81 (01) :138-139
[2]   Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201 [J].
Derungs, Adrian ;
Schwaninger, Andrea E. ;
Mansella, Gregory ;
Bingisser, Roland ;
Kraemer, Thomas ;
Liechti, Matthias E. .
FORENSIC TOXICOLOGY, 2013, 31 (01) :164-171
[3]   CAPILLARY GAS-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF N-BUTYL-P-AMINOBENZOATE AND LIDOCAINE IN PLASMA SAMPLES [J].
GROULS, RJE ;
MACHIELSEN, E ;
KORSTEN, HHM ;
HELLEBREKERS, LJ ;
BREIMER, DD ;
ACKERMAN, EW .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 673 (01) :51-57
[4]   The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™) [J].
Kavanagh, Pierce ;
Angelov, Daniel ;
O'Brien, John ;
Power, John D. ;
McDermott, Sean D. ;
Talbot, Brian ;
Fox, John ;
O'Donnell, Cora ;
Christie, Rachel .
DRUG TESTING AND ANALYSIS, 2013, 5 (04) :247-253
[5]   Toxicological Findings of Synthetic Cannabinoids in Recreational Users [J].
Kronstrand, Robert ;
Roman, Markus ;
Andersson, Mikael ;
Eklund, Arne .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2013, 37 (08) :534-541
[6]   Severe Toxicity Following Synthetic Cannabinoid Ingestion [J].
Lapoint, J. ;
James, L. P. ;
Moran, C. L. ;
Nelson, L. S. ;
Hoffman, R. S. ;
Moran, J. H. .
CLINICAL TOXICOLOGY, 2011, 49 (08) :760-764
[7]  
Lonati D, 2011, CLIN TOXICOL, V49, P199
[8]   Indoles and related compounds as cannabinoid ligands [J].
Manera, Clementina ;
Tuccinardi, Tiziano ;
Martinelli, Adriano .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (04) :370-387
[9]   First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201 [J].
McQuade, David ;
Hudson, Simon ;
Dargan, Paul I. ;
Wood, David M. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) :373-376
[10]   Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2 [J].
Mir, Arshid ;
Obafemi, Adebisi ;
Young, Amy ;
Kane, Colin .
PEDIATRICS, 2011, 128 (06) :E1622-E1627